Uncategorized Archives - Page 78 of 87 - PsychedelicNewsWire (PNW)

FridayNov 02, 2018 11:31 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Focusing on its New Subsidiaries and Intellectual Property

Lexaria has its patented DehydraTECH drug delivery platform The company’s technology is a complementary layer that works with the other research being done on cannabinoids Lexaria has a robust IP portfolio and four new subsidiary companies A drug delivery platform pioneer, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its DehydraTECH technology. The company’s technology changes the way in which edible cannabinoids absorb into the body. The DehydraTECH drug delivery platform is patented for cannabidiol and all other non-psychoactive cannabinoids and enables the transportation of bioactive substances via oral ingestion. A research-driven enterprise, Lexaria Bioscience is based…

MondayOct 29, 2018 12:21 pm

Earth Science Tech, Inc. (ETST) Taps into Highly Promising CBD Beverage Market

Earth Science Tech plans to enter the CBD beverages market through the development of its own full-spectrum CBD drink The product is developed on the basis of a University of Central Oklahoma Provisional Patent Industry experts predict rapid growth of the CBD beverages market, which is still in the early stages of development and offers excellent opportunities Earth Science Tech, Inc. (OTCQB: ETST) announced that it has started work on the formulation of a full-spectrum CBD beverage. The biotech company that focuses on CBD, pharmaceutical and nutraceutical products will be utilizing its University of Central Oklahoma Provisional Patent to develop…

WednesdayOct 24, 2018 10:37 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Receives Two US Patents, Bringing Total to 10 in First Patent Family across US and Australia

The two new patents are related to certain cannabinoid-infused beverage compositions using LXRP’s DehydraTECH technology Globally, LXRP has filed some 50 patent applications as the company expands its IP portfolio; LXRP hopes to receive two more granted patents from Australia by year end, giving it 12 in total LXRP out-licenses its technology, which promotes healthier and faster ingestion; the company seeks accelerated patent application examinations in Australia based on the U.S. patents Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has been granted two new U.S. patents based on cannabinoid-infused beverage compositions using its DehydraTECH ingestion technology platform. The company is…

TuesdayOct 16, 2018 11:28 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Completes Establishment of Four Wholly Owned Subsidiaries

Lexaria’s technology changes the manner in which edible cannabinoids enter the body The company out-licenses its DehydraTECH drug delivery platform Lexaria recently announced the creation of four wholly owned subsidiaries A research-driven company, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is the only company globally that has been awarded a patent for the improved delivery of all cannabinoids. It has developed and out-licenses its DehydraTECH technology – a drug delivery platform. This technology is a complementary layer that works with other research and development being conducted on cannabinoids and, as such, is an enabling technology, not a competing one. Lexaria…

FridayOct 12, 2018 11:15 am

American Premium Water Corp. (HIPH) is “One to Watch”

Revenue from CBD-infused beverages could become a $260 million market in the U.S. by 2022 with THC-infused beverages raking in about $340 million Rising global trend in popularity of wellness beverages includes CBD-infused drinks Investor interest in CBD increasing following U.S. Food and Drug Administration clearance for first cannabis-derived drug to be sold in U.S. American Premium Water Corp. (OTC: HIPH), headquartered in Playa Vista, California, is a diversified holding company, manufacturer, distributor and marketer of branded consumer products. HIPH, the acronym for “Hi-Power of Hydro,” maintains a portfolio of subsidiaries catering to the health-conscious consumer and luxury fashion brand…

MondayOct 01, 2018 1:05 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Changing the Efficiency and Future of Drug Delivery

Focused on discovering new technologies that deliver cannabinoids and other beneficial molecules to the bloodstream Bypassing the negative side effects of lighting up Crossing blood brain barrier Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is focused on discovering new technologies that deliver cannabinoids and other lipophilic (fat soluble) beneficial molecules to the bloodstream through efficient and healthy ingestion. The first step to discovering how to deliver a higher percentage into the human bloodstream was to find a way to protect the molecules on their journey through the gastrointestinal system. It was discovered that fats are an excellent conduit, increasing absorption…

WednesdaySep 05, 2018 2:25 pm

Cannabis Strategic Ventures, Inc. (NUGS) Continues Expansion with Move into CBD Pet Food Supplement Line

Acquired controlling interest in The Asher House Pet CBD brand, produced with full-spectrum, whole-plant hemp, free of THC and pesticides An estimated $72.13 billion will be spent on pets by Americans during 2018, with over $33 billion spent on veterinary care, supplies and OTC medicines Percentage of U.S. households with a pet increased from 56 percent in 1988 to 68 percent in 2018 Sales of CBD products to U.S. consumers estimated to reach $2.1 billion by 2020, with $450 million coming from hemp-based sources The U.S. cannabis market is growing at an accelerated rate; industry analysts projecting a $50 billion…

WednesdaySep 05, 2018 1:30 pm

Sugarmade, Inc. (SGMD) Establishing Strong Position in Billion-Dollar Hemp Industry

Sugarmade announces $1 million investment in hemp company growing ultra-high CBD industrial hemp Sugarmade CEO becomes Hempistry advisor, shareholder ‘Lucrative’ supply agreement offers tremendous opportunity in fast-growing sector One of the largest publicly traded hydroponics supply companies, Sugarmade, Inc. (OTC: SGMD) is joining the ranks of savvy businesses that have chosen to enter the burgeoning hemp market. Last year, the U.S. hemp industry topped out at an impressive $820 million in revenue, and that total is expected to reach more than $1 billion by the end of 2018, with a 14 percent compound annual growth rate forecast through 2022. Sugarmade…

ThursdayAug 23, 2018 10:04 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Drug Delivery Platform Takes Dosage from Zero to 203 in 15 Minutes

DehydraTECH™ methodology offers safer alternative to smoking Possible nicotine delivery platform for Big Tobacco Several licensing agreements for technology already signed Formula One racing is not the only place to find speed. The drug delivery platform DehydraTECH™, developed by Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), has proven that it’s just as fast. In recent in vivo tests, the technology delivered 203 nanograms per milliliter (ng/mL) of nicotine in 15 minutes, 70 percent more than the control. Such rapidity may rival smoking; particularly as new research (http://cnw.fm/gi1Aw) suggests that “nicotine takes much longer than previously thought to reach peak levels in…

FridayAug 17, 2018 1:42 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Sees Progress in Revolutionary Alternative to Smoking for Drug Delivery

Smoking-related deaths have reached six million a year worldwide Lexaria’s patented drug delivery platform aims to deliver commonly smoked drugs in a non-smoking form factor that sidesteps smoking’s hazards Second round of testing continues to indicate that patented DehydraTECH™ platform provides rapid delivery with high bioavailability As world drug industry regulations undergo revolutionary change and increasingly healthy populations find themselves challenged to meet the cares of old age, Canadian biotechnology company Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is forging a path that establishes it as a pioneer in the field of drug delivery platforms. Lexaria’s mission is to ensure…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Uncategorized